Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029
The urinalysis market is valued at an estimated USD 4.3 billion in 2024 and is projected to reach USD 6.8 billion by 2029 at a CAGR of 9.6% during the forecast period.
Due to rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes and liver & kidney diseases is expected to increase significantly. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for the basic metabolic panel, lipid profile, and liver & renal panel tests. These tests are performed by urinalysis analyzers, thereby positively impacting market growth. The global rise in the geriatric population is considered a key factor in driving the growth of the urinalysis market.
“Consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period.”
Based on product, the urinalysis market is bifurcated into consumables and instruments. The consumables segment in the urinalysis market is experiencing substantial growth. The recurrent requirement and purchase of these consumables is one of the primary reasons for the high growth rate of this market segment. Also, the wider range of consumables available in the market for urinalysis is contributing significantly to its larger share. The urinalysis market offers variety of consumables catering to different testing needs. Development of new dipsticks with more test parameters will further increase their demand in future.
“Disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period.”
The urinalysis market is bifurcated into disease screening and pregnancy & fertility testing. Disease screening segment is expected to account for the highest CAGR during the forecast period. As urinalysis plays an integral role in diagnosing such diseases, the urinalysis market for disease screening applications is expected to grow in the coming years. Additionally, many conditions detectable through urinalysis, such as early-stage kidney disease and diabetes, often do not exhibit symptoms until they are advanced. Regular urinalysis enables early detection and intervention, which can significantly improve patient outcomes and reduce long-term healthcare costs. This will bolster the extensive use of urinalysis in disease screening, ensuring its position as the largest segment in the market.
“Asia Pacific: The fastest-growing region in urinalysis market.”
The worldwide market for urinalysis is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is poised to experience the most notable CAGR within the urinalysis market. The high growth in the Asia Pacific can be attributed to the increasing government efforts to increase awareness about early disease detection, growing per capita income, the expansion of private-sector hospitals to rural areas in various Asia Pacific countries, and the presence of high-growth markets in the region.
The break-up of the profile of primary participants in the urinalysis market:
Research Coverage:
This research report categorizes the urinalysis market by product (Consumables [Pregnancy & Fertility Kits, Dipsticks, Disposables, Reagents], Instruments [Automated Urine Analyzers {Integrated Urine Analyzers, Sediment Urine Analyzers (Microscopy Analyzers, Flow Cytometry Analyzers), Biochemical Urine Analyzers, Semi-automated Urine Analyzers}, and Point-of-care Urine Analyzers], by test type (Pregnancy & Fertility Tests, Biochemical Tests [Laboratory Tests, PoC Tests], and Sediment Urinalysis), by application (Disease Screening [Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, and Other Disease Screening Applications] and Pregnancy & Fertility Testing), by end user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the urinalysis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urinalysis market. Competitive analysis of upcoming startups in the urinalysis market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urinalysis market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
Due to rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes and liver & kidney diseases is expected to increase significantly. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for the basic metabolic panel, lipid profile, and liver & renal panel tests. These tests are performed by urinalysis analyzers, thereby positively impacting market growth. The global rise in the geriatric population is considered a key factor in driving the growth of the urinalysis market.
“Consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period.”
Based on product, the urinalysis market is bifurcated into consumables and instruments. The consumables segment in the urinalysis market is experiencing substantial growth. The recurrent requirement and purchase of these consumables is one of the primary reasons for the high growth rate of this market segment. Also, the wider range of consumables available in the market for urinalysis is contributing significantly to its larger share. The urinalysis market offers variety of consumables catering to different testing needs. Development of new dipsticks with more test parameters will further increase their demand in future.
“Disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period.”
The urinalysis market is bifurcated into disease screening and pregnancy & fertility testing. Disease screening segment is expected to account for the highest CAGR during the forecast period. As urinalysis plays an integral role in diagnosing such diseases, the urinalysis market for disease screening applications is expected to grow in the coming years. Additionally, many conditions detectable through urinalysis, such as early-stage kidney disease and diabetes, often do not exhibit symptoms until they are advanced. Regular urinalysis enables early detection and intervention, which can significantly improve patient outcomes and reduce long-term healthcare costs. This will bolster the extensive use of urinalysis in disease screening, ensuring its position as the largest segment in the market.
“Asia Pacific: The fastest-growing region in urinalysis market.”
The worldwide market for urinalysis is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is poised to experience the most notable CAGR within the urinalysis market. The high growth in the Asia Pacific can be attributed to the increasing government efforts to increase awareness about early disease detection, growing per capita income, the expansion of private-sector hospitals to rural areas in various Asia Pacific countries, and the presence of high-growth markets in the region.
The break-up of the profile of primary participants in the urinalysis market:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%
Research Coverage:
This research report categorizes the urinalysis market by product (Consumables [Pregnancy & Fertility Kits, Dipsticks, Disposables, Reagents], Instruments [Automated Urine Analyzers {Integrated Urine Analyzers, Sediment Urine Analyzers (Microscopy Analyzers, Flow Cytometry Analyzers), Biochemical Urine Analyzers, Semi-automated Urine Analyzers}, and Point-of-care Urine Analyzers], by test type (Pregnancy & Fertility Tests, Biochemical Tests [Laboratory Tests, PoC Tests], and Sediment Urinalysis), by application (Disease Screening [Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, and Other Disease Screening Applications] and Pregnancy & Fertility Testing), by end user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the urinalysis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urinalysis market. Competitive analysis of upcoming startups in the urinalysis market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urinalysis market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer, rising geriatric population and subsequent increase in age-associated diseases, and increasing adoption of PoC urine diagnostic tests), opportunities (Growth opportunities in emerging countries, technological advancements in urine analyzers, and increasing government initiatives and funding for preventive care), restraints (Availability of refurbished urine analyzers and high capital investments and lack of skilled laboratory technicians), and challenges (Changing regulatory landscape) influencing the growth of the urinalysis market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urinalysis market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the urinalysis market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinalysis market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), and Danaher (US).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS OF STUDY
1.4 STUDY SCOPE
1.4.1 MARKET SEGMENTATION
1.4.2 REGIONS COVERED
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 1 URINALYSIS MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 2: Presentations of companies and primary interviews
2.3.1.3 Growth forecast
2.3.1.4 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 URINALYSIS MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE
2.6 STUDY ASSUMPTIONS
2.7 GROWTH RATE ASSUMPTIONS
2.8 RISK ASSESSMENT
2.8.1 URINALYSIS MARKET: RISK ASSESSMENT
2.9 RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 8 URINALYSIS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 9 URINALYSIS MARKET, BY TEST TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 10 URINALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 11 URINALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 12 URINALYSIS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 URINALYSIS MARKET OVERVIEW
FIGURE 13 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
4.2 URINALYSIS MARKET SHARE, BY PRODUCT, 2024 VS. 2029
FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE URINALYSIS PRODUCTS MARKET
4.3 URINALYSIS MARKET SHARE, BY TEST TYPE, 2024 VS. 2029
FIGURE 15 PREGNANCY & FERTILITY TESTS SEGMENT TO DOMINATE MARKET
4.4 URINALYSIS MARKET SHARE, BY APPLICATION, 2024 VS. 2029
FIGURE 16 DISEASE SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 URINALYSIS MARKET SHARE, BY END USER, 2024 VS. 2029
FIGURE 17 DIAGNOSTIC LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
4.6 URINALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer
TABLE 1 ESTIMATED NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES WORLDWIDE, BY REGION, 2021 VS. 2030 VS. 2045
5.2.1.2 Rising geriatric population and subsequent increase in age-associated diseases
TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION, 2022 VS. 2030 VS. 2050
5.2.1.3 Increasing adoption of PoC urine diagnostic tests
5.2.2 RESTRAINTS
5.2.2.1 Availability of refurbished urine analyzers
5.2.2.2 High capital investments and lack of skilled laboratory technicians
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging countries
5.2.3.2 Technological advancements in urine analyzers
5.2.3.3 Increasing government initiatives and funding for preventive care
5.2.4 CHALLENGES
5.2.4.1 Changing regulatory landscape
5.3 PRICING ANALYSIS
TABLE 3 INDICATIVE PRICING FOR URINALYSIS PRODUCTS
TABLE 4 AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY REGION
5.4 PATENT ANALYSIS
FIGURE 20 PATENT ANALYSIS FOR FLOW CYTOMETRY (JANUARY 2014–DECEMBER 2023)
5.4.1 LIST OF MAJOR PATENTS
5.5 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS OF URINALYSIS MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 22 URINALYSIS MARKET: SUPPLY CHAIN ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 5 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 6 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
5.8 ECOSYSTEM ANALYSIS
FIGURE 23 URINALYSIS MARKET: ECOSYSTEM ANALYSIS
5.8.1 URINALYSIS MARKET: ROLE IN ECOSYSTEM
5.9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 24 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 REGULATORY LANDSCAPE
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 Canada
5.10.2 EUROPE
TABLE 8 EUROPE: CLASSIFICATION OF DEVICES
5.10.3 ASIA PACIFIC
5.10.3.1 China
5.10.3.2 Japan
TABLE 9 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.10.3.3 India
5.10.4 LATIN AMERICA
5.10.4.1 Brazil
5.10.4.2 Mexico
5.10.5 MIDDLE EAST
5.10.5.1 Africa
5.10.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TECHNOLOGY ANALYSIS
5.11.1 KEY TECHNOLOGY
5.11.1.1 Automated urine analyzers
5.11.2 COMPLEMENTARY TECHNOLOGY
5.11.2.1 Point-of-care urine analyzers
5.11.3 ADJACENT TECHNOLOGY
5.11.3.1 Multiplex PCR
5.12 KEY CONFERENCES & EVENTS IN 2024–2025
TABLE 15 URINALYSIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR URINALYSIS MARKET
FIGURE 25 REVENUE SHIFT IN URINALYSIS MARKET
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS (%)
5.14.2 BUYING CRITERIA
FIGURE 27 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
TABLE 17 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
5.15 INVESTMENT & FUNDING SCENARIO
FIGURE 28 URINALYSIS MARKET: INVESTMENT & FUNDING SCENARIO
5.16 CASE STUDY ANALYSIS
5.17 IMPACT OF ARTIFICIAL INTELLIGENCE ON URINALYSIS MARKET
6 URINALYSIS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 18 URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
6.1.1 PRIMARY NOTES
6.1.1.1 Key industry insights
6.2 CONSUMABLES
TABLE 19 KEY PRODUCTS IN URINALYSIS CONSUMABLES MARKET
TABLE 20 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 21 URINALYSIS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 22 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 23 EUROPE: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 24 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 25 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.1 PREGNANCY & FERTILITY KITS
6.2.1.1 Rapid accessibility and testing convenience to drive market
TABLE 26 KEY PRODUCTS IN PREGNANCY & FERTILITY KITS MARKET
TABLE 27 PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 NORTH AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 EUROPE: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LATIN AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.2 DIPSTICKS
6.2.2.1 Low cost to increase adoption
TABLE 32 KEY PRODUCTS IN URINALYSIS DIPSTICKS/URINE TEST STRIPS MARKET
TABLE 33 DIPSTICKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 34 NORTH AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 EUROPE: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 ASIA PACIFIC: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 LATIN AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.3 REAGENTS
6.2.3.1 Increasing use of controls and calibrators to drive market
TABLE 38 KEY PRODUCTS IN URINALYSIS REAGENTS MARKET
TABLE 39 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 40 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.4 DISPOSABLES
6.2.4.1 Wise usage in hospitals and clinical laboratories to support market growth
TABLE 44 DISPOSABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 45 NORTH AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 EUROPE: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 ASIA PACIFIC: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 LATIN AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3 INSTRUMENTS
TABLE 49 KEY PRODUCTS IN URINALYSIS INSTRUMENTS MARKET
TABLE 50 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 51 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 52 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1 AUTOMATED URINE ANALYZERS
TABLE 56 KEY PRODUCTS IN AUTOMATED URINE ANALYZERS MARKET
TABLE 57 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 58 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.1 Integrated urine analyzers
6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers
TABLE 63 KEY PRODUCTS IN INTEGRATED URINE ANALYZERS MARKET
TABLE 64 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 EUROPE: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 ASIA PACIFIC: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 LATIN AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2 Sediment urine analyzers
TABLE 69 KEY PRODUCTS IN SEDIMENT URINE ANALYZERS MARKET
TABLE 70 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 71 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 72 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2.1 Flow cytometry analyzers
6.3.1.2.1.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption
TABLE 76 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 77 NORTH AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 EUROPE: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 ASIA PACIFIC: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 LATIN AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2.2 Microscopy analyzers
6.3.1.2.2.1 Increased speed and accuracy of analysis to drive adoption
TABLE 81 MICROSCOPY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 ASIA PACIFIC: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 LATIN AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.3 Biochemical urine analyzers
6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market
TABLE 86 KEY PRODUCTS IN BIOCHEMICAL URINE ANALYZERS MARKET
TABLE 87 BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 EUROPE: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 ASIA PACIFIC: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 LATIN AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.2 SEMI-AUTOMATED URINE ANALYZERS
6.3.2.1 Extensive use in hospitals & clinics to drive segment growth
TABLE 92 KEY PRODUCTS IN SEMI-AUTOMATED URINE ANALYZERS MARKET
TABLE 93 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 EUROPE: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 LATIN AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.3 POINT-OF-CARE URINE ANALYZERS
6.3.3.1 Need for rapid testing to drive demand for PoC urine analyzers
TABLE 98 KEY PRODUCTS IN POINT-OF-CARE URINE ANALYZERS MARKET
TABLE 99 POC URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 100 NORTH AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 EUROPE: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 ASIA PACIFIC: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 LATIN AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
7 URINALYSIS MARKET, BY TEST TYPE
7.1 INTRODUCTION
TABLE 104 URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
7.1.1 PRIMARY NOTES
7.1.1.1 Key industry insights
7.2 PREGNANCY & FERTILITY TESTS
7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE MARKET
TABLE 105 KEY PRODUCTS IN PREGNANCY & FERTILITY TESTS MARKET
TABLE 106 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 107 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 BIOCHEMICAL TESTS
TABLE 111 KEY PRODUCTS IN BIOCHEMICAL TESTS MARKET
TABLE 112 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 114 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.1 LABORATORY TESTS
7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market
TABLE 118 KEY PRODUCTS IN LABORATORY TESTS MARKET
TABLE 119 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 120 NORTH AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 EUROPE: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 LATIN AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.2 POC TESTS
7.3.2.1 Convenience of PoC testing to drive segment growth
TABLE 124 KEY PRODUCTS IN POC TESTS MARKET
TABLE 125 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 126 NORTH AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 EUROPE: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 ASIA PACIFIC: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 LATIN AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
7.4 SEDIMENT URINALYSIS
7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET
TABLE 130 KEY PRODUCTS IN SEDIMENT URINALYSIS MARKET
TABLE 131 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 132 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
8 URINALYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 136 URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
8.1.1 PRIMARY NOTES
8.1.1.1 Key industry insights
8.2 DISEASE SCREENING
TABLE 137 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 139 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.1 URINARY TRACT INFECTIONS
8.2.1.1 Increasing prevalence of UTIs to drive segment growth
TABLE 143 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 144 NORTH AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2 KIDNEY DISEASES
8.2.2.1 Rapidly growing geriatric population and increasing prevalence of kidney diseases to fuel segment growth
TABLE 148 TOTAL GERIATRIC POPULATION, 2022 VS. 2030 VS. 2050 (%)
TABLE 149 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2022–2029 (USD MILLION)
TABLE 150 NORTH AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 EUROPE: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 ASIA PACIFIC: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 LATIN AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.3 DIABETES
8.2.3.1 Development of advanced analytical tools to drive market
TABLE 154 ESTIMATED NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION)
TABLE 155 TOP TEN COUNTRIES/TERRITORIES WITH HIGHEST TOTAL HEALTH EXPENDITURE (USD) DUE TO DIABETES IN 2021, 20–79 YEARS (USD BILLION)
TABLE 156 URINALYSIS MARKET FOR DIABETES, BY REGION, 2022–2029 (USD MILLION)
TABLE 157 NORTH AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 EUROPE: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 ASIA PACIFIC: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 LATIN AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.4 LIVER DISEASES
8.2.4.1 High prevalence of liver diseases to support market growth
TABLE 161 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2022–2029 (USD MILLION)
TABLE 162 NORTH AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 163 EUROPE: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 164 ASIA PACIFIC: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 LATIN AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.5 OTHER DISEASE SCREENING APPLICATIONS
TABLE 166 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 167 NORTH AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 EUROPE: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 LATIN AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
8.3 PREGNANCY & FERTILITY TESTING
8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
TABLE 171 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 172 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
9 URINALYSIS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 176 URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2 DIAGNOSTIC LABORATORIES
9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
TABLE 177 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 178 NORTH AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 EUROPE: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 ASIA PACIFIC: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 LATIN AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
9.3 HOSPITALS & CLINICS
9.3.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH
TABLE 182 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 183 NORTH AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 EUROPE: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 ASIA PACIFIC: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186 LATIN AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
9.4 HOME CARE SETTINGS
9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
TABLE 187 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION)
TABLE 188 NORTH AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 EUROPE: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 ASIA PACIFIC: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 LATIN AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
9.5 RESEARCH LABORATORIES & INSTITUTES
9.5.1 DEVELOPMENT OF INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
TABLE 192 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 193 NORTH AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 EUROPE: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 ASIA PACIFIC: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 LATIN AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
10 URINALYSIS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 197 URINALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
TABLE 198 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 200 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 202 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 205 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 206 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 207 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 208 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 Rising prevalence of chronic diseases to drive market
TABLE 209 US: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 210 US: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 211 US: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 213 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 214 US: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 215 US: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 216 US: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 217 US: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 218 US: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Rising burden of CKD to augment market
TABLE 219 CANADA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 220 CANADA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 221 CANADA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 222 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 223 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 224 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 225 CANADA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 CANADA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 227 CANADA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 228 CANADA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3 EUROPE
TABLE 229 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 231 EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 232 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 233 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 234 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 235 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 236 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 237 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 238 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 239 EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Increasing healthcare expenditure to fuel market growth
TABLE 240 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 241 GERMANY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 242 GERMANY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 243 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 245 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 246 GERMANY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 247 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 248 GERMANY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 249 GERMANY: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS OF STUDY
1.4 STUDY SCOPE
1.4.1 MARKET SEGMENTATION
1.4.2 REGIONS COVERED
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 1 URINALYSIS MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 2: Presentations of companies and primary interviews
2.3.1.3 Growth forecast
2.3.1.4 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 URINALYSIS MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE
2.6 STUDY ASSUMPTIONS
2.7 GROWTH RATE ASSUMPTIONS
2.8 RISK ASSESSMENT
2.8.1 URINALYSIS MARKET: RISK ASSESSMENT
2.9 RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 8 URINALYSIS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 9 URINALYSIS MARKET, BY TEST TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 10 URINALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 11 URINALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 12 URINALYSIS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 URINALYSIS MARKET OVERVIEW
FIGURE 13 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
4.2 URINALYSIS MARKET SHARE, BY PRODUCT, 2024 VS. 2029
FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE URINALYSIS PRODUCTS MARKET
4.3 URINALYSIS MARKET SHARE, BY TEST TYPE, 2024 VS. 2029
FIGURE 15 PREGNANCY & FERTILITY TESTS SEGMENT TO DOMINATE MARKET
4.4 URINALYSIS MARKET SHARE, BY APPLICATION, 2024 VS. 2029
FIGURE 16 DISEASE SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 URINALYSIS MARKET SHARE, BY END USER, 2024 VS. 2029
FIGURE 17 DIAGNOSTIC LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
4.6 URINALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer
TABLE 1 ESTIMATED NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES WORLDWIDE, BY REGION, 2021 VS. 2030 VS. 2045
5.2.1.2 Rising geriatric population and subsequent increase in age-associated diseases
TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION, 2022 VS. 2030 VS. 2050
5.2.1.3 Increasing adoption of PoC urine diagnostic tests
5.2.2 RESTRAINTS
5.2.2.1 Availability of refurbished urine analyzers
5.2.2.2 High capital investments and lack of skilled laboratory technicians
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging countries
5.2.3.2 Technological advancements in urine analyzers
5.2.3.3 Increasing government initiatives and funding for preventive care
5.2.4 CHALLENGES
5.2.4.1 Changing regulatory landscape
5.3 PRICING ANALYSIS
TABLE 3 INDICATIVE PRICING FOR URINALYSIS PRODUCTS
TABLE 4 AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY REGION
5.4 PATENT ANALYSIS
FIGURE 20 PATENT ANALYSIS FOR FLOW CYTOMETRY (JANUARY 2014–DECEMBER 2023)
5.4.1 LIST OF MAJOR PATENTS
5.5 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS OF URINALYSIS MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 22 URINALYSIS MARKET: SUPPLY CHAIN ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 5 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 6 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
5.8 ECOSYSTEM ANALYSIS
FIGURE 23 URINALYSIS MARKET: ECOSYSTEM ANALYSIS
5.8.1 URINALYSIS MARKET: ROLE IN ECOSYSTEM
5.9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 24 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 REGULATORY LANDSCAPE
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 Canada
5.10.2 EUROPE
TABLE 8 EUROPE: CLASSIFICATION OF DEVICES
5.10.3 ASIA PACIFIC
5.10.3.1 China
5.10.3.2 Japan
TABLE 9 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.10.3.3 India
5.10.4 LATIN AMERICA
5.10.4.1 Brazil
5.10.4.2 Mexico
5.10.5 MIDDLE EAST
5.10.5.1 Africa
5.10.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TECHNOLOGY ANALYSIS
5.11.1 KEY TECHNOLOGY
5.11.1.1 Automated urine analyzers
5.11.2 COMPLEMENTARY TECHNOLOGY
5.11.2.1 Point-of-care urine analyzers
5.11.3 ADJACENT TECHNOLOGY
5.11.3.1 Multiplex PCR
5.12 KEY CONFERENCES & EVENTS IN 2024–2025
TABLE 15 URINALYSIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR URINALYSIS MARKET
FIGURE 25 REVENUE SHIFT IN URINALYSIS MARKET
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS (%)
5.14.2 BUYING CRITERIA
FIGURE 27 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
TABLE 17 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
5.15 INVESTMENT & FUNDING SCENARIO
FIGURE 28 URINALYSIS MARKET: INVESTMENT & FUNDING SCENARIO
5.16 CASE STUDY ANALYSIS
5.17 IMPACT OF ARTIFICIAL INTELLIGENCE ON URINALYSIS MARKET
6 URINALYSIS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 18 URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
6.1.1 PRIMARY NOTES
6.1.1.1 Key industry insights
6.2 CONSUMABLES
TABLE 19 KEY PRODUCTS IN URINALYSIS CONSUMABLES MARKET
TABLE 20 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 21 URINALYSIS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 22 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 23 EUROPE: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 24 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 25 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.1 PREGNANCY & FERTILITY KITS
6.2.1.1 Rapid accessibility and testing convenience to drive market
TABLE 26 KEY PRODUCTS IN PREGNANCY & FERTILITY KITS MARKET
TABLE 27 PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 NORTH AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 EUROPE: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LATIN AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.2 DIPSTICKS
6.2.2.1 Low cost to increase adoption
TABLE 32 KEY PRODUCTS IN URINALYSIS DIPSTICKS/URINE TEST STRIPS MARKET
TABLE 33 DIPSTICKS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 34 NORTH AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 EUROPE: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 ASIA PACIFIC: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 LATIN AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.3 REAGENTS
6.2.3.1 Increasing use of controls and calibrators to drive market
TABLE 38 KEY PRODUCTS IN URINALYSIS REAGENTS MARKET
TABLE 39 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 40 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.4 DISPOSABLES
6.2.4.1 Wise usage in hospitals and clinical laboratories to support market growth
TABLE 44 DISPOSABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 45 NORTH AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 EUROPE: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 ASIA PACIFIC: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 LATIN AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3 INSTRUMENTS
TABLE 49 KEY PRODUCTS IN URINALYSIS INSTRUMENTS MARKET
TABLE 50 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 51 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 52 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1 AUTOMATED URINE ANALYZERS
TABLE 56 KEY PRODUCTS IN AUTOMATED URINE ANALYZERS MARKET
TABLE 57 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 58 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.1 Integrated urine analyzers
6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers
TABLE 63 KEY PRODUCTS IN INTEGRATED URINE ANALYZERS MARKET
TABLE 64 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 EUROPE: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 ASIA PACIFIC: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 LATIN AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2 Sediment urine analyzers
TABLE 69 KEY PRODUCTS IN SEDIMENT URINE ANALYZERS MARKET
TABLE 70 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 71 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 72 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2.1 Flow cytometry analyzers
6.3.1.2.1.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption
TABLE 76 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 77 NORTH AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 EUROPE: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 ASIA PACIFIC: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 LATIN AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2.2 Microscopy analyzers
6.3.1.2.2.1 Increased speed and accuracy of analysis to drive adoption
TABLE 81 MICROSCOPY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 ASIA PACIFIC: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 LATIN AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.3 Biochemical urine analyzers
6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market
TABLE 86 KEY PRODUCTS IN BIOCHEMICAL URINE ANALYZERS MARKET
TABLE 87 BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 EUROPE: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 ASIA PACIFIC: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 LATIN AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.2 SEMI-AUTOMATED URINE ANALYZERS
6.3.2.1 Extensive use in hospitals & clinics to drive segment growth
TABLE 92 KEY PRODUCTS IN SEMI-AUTOMATED URINE ANALYZERS MARKET
TABLE 93 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 EUROPE: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 LATIN AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.3 POINT-OF-CARE URINE ANALYZERS
6.3.3.1 Need for rapid testing to drive demand for PoC urine analyzers
TABLE 98 KEY PRODUCTS IN POINT-OF-CARE URINE ANALYZERS MARKET
TABLE 99 POC URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 100 NORTH AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 EUROPE: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 ASIA PACIFIC: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 LATIN AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
7 URINALYSIS MARKET, BY TEST TYPE
7.1 INTRODUCTION
TABLE 104 URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
7.1.1 PRIMARY NOTES
7.1.1.1 Key industry insights
7.2 PREGNANCY & FERTILITY TESTS
7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE MARKET
TABLE 105 KEY PRODUCTS IN PREGNANCY & FERTILITY TESTS MARKET
TABLE 106 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 107 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 BIOCHEMICAL TESTS
TABLE 111 KEY PRODUCTS IN BIOCHEMICAL TESTS MARKET
TABLE 112 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 114 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.1 LABORATORY TESTS
7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market
TABLE 118 KEY PRODUCTS IN LABORATORY TESTS MARKET
TABLE 119 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 120 NORTH AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 EUROPE: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 LATIN AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.2 POC TESTS
7.3.2.1 Convenience of PoC testing to drive segment growth
TABLE 124 KEY PRODUCTS IN POC TESTS MARKET
TABLE 125 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 126 NORTH AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 EUROPE: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 ASIA PACIFIC: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 LATIN AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
7.4 SEDIMENT URINALYSIS
7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET
TABLE 130 KEY PRODUCTS IN SEDIMENT URINALYSIS MARKET
TABLE 131 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 132 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
8 URINALYSIS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 136 URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
8.1.1 PRIMARY NOTES
8.1.1.1 Key industry insights
8.2 DISEASE SCREENING
TABLE 137 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 139 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.1 URINARY TRACT INFECTIONS
8.2.1.1 Increasing prevalence of UTIs to drive segment growth
TABLE 143 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 144 NORTH AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2 KIDNEY DISEASES
8.2.2.1 Rapidly growing geriatric population and increasing prevalence of kidney diseases to fuel segment growth
TABLE 148 TOTAL GERIATRIC POPULATION, 2022 VS. 2030 VS. 2050 (%)
TABLE 149 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2022–2029 (USD MILLION)
TABLE 150 NORTH AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 EUROPE: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 ASIA PACIFIC: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 LATIN AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.3 DIABETES
8.2.3.1 Development of advanced analytical tools to drive market
TABLE 154 ESTIMATED NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION)
TABLE 155 TOP TEN COUNTRIES/TERRITORIES WITH HIGHEST TOTAL HEALTH EXPENDITURE (USD) DUE TO DIABETES IN 2021, 20–79 YEARS (USD BILLION)
TABLE 156 URINALYSIS MARKET FOR DIABETES, BY REGION, 2022–2029 (USD MILLION)
TABLE 157 NORTH AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 EUROPE: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 ASIA PACIFIC: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 LATIN AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.4 LIVER DISEASES
8.2.4.1 High prevalence of liver diseases to support market growth
TABLE 161 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2022–2029 (USD MILLION)
TABLE 162 NORTH AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 163 EUROPE: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 164 ASIA PACIFIC: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 LATIN AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.5 OTHER DISEASE SCREENING APPLICATIONS
TABLE 166 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 167 NORTH AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 EUROPE: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 LATIN AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
8.3 PREGNANCY & FERTILITY TESTING
8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
TABLE 171 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 172 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
9 URINALYSIS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 176 URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2 DIAGNOSTIC LABORATORIES
9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
TABLE 177 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 178 NORTH AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 EUROPE: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 ASIA PACIFIC: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 LATIN AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
9.3 HOSPITALS & CLINICS
9.3.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH
TABLE 182 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 183 NORTH AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 EUROPE: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 ASIA PACIFIC: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186 LATIN AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
9.4 HOME CARE SETTINGS
9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
TABLE 187 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION)
TABLE 188 NORTH AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 EUROPE: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 ASIA PACIFIC: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 LATIN AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
9.5 RESEARCH LABORATORIES & INSTITUTES
9.5.1 DEVELOPMENT OF INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
TABLE 192 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 193 NORTH AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 EUROPE: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 ASIA PACIFIC: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 LATIN AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
10 URINALYSIS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 197 URINALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
TABLE 198 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 200 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 202 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 205 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 206 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 207 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 208 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 Rising prevalence of chronic diseases to drive market
TABLE 209 US: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 210 US: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 211 US: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 213 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 214 US: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 215 US: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 216 US: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 217 US: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 218 US: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Rising burden of CKD to augment market
TABLE 219 CANADA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 220 CANADA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 221 CANADA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 222 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 223 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 224 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 225 CANADA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 CANADA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 227 CANADA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 228 CANADA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3 EUROPE
TABLE 229 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 231 EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 232 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 233 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 234 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 235 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 236 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 237 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 238 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 239 EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Increasing healthcare expenditure to fuel market growth
TABLE 240 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 241 GERMANY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 242 GERMANY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 243 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 245 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
TABLE 246 GERMANY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 247 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 248 GERMANY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
TABLE 249 GERMANY: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
